Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Registration - 2016 > Bulk Manufacturer of Controlled Substances Registration

Manufacturers Notice of Registration - 2016

[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52908-52909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18921]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.


SUMMARY: Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.

[[Page 52909]]

Company FR Docket Published
Noramco, Inc. 81 FR 7587 February 12, 2016
Cayman Chemical Company 81 FR 9217 February 24, 2016
Janssen Pharmaceutical, Inc. 81 FR 9219 February 24, 2016
Insys Therapeutics, Inc. 81 FR 9220 February 24, 2016
Siemens Healthcare Diagnostics, Inc. 81 FR 15565 March 23, 2016
Siegfried USA, LLC 81 FR 15567 March 23, 2016
Patheon Pharmaceuticals, Inc. 81 FR 15571 March 23, 2016
Navinta, LLC 81 FR 20418 April 7, 2016
Patheon API Manufacturing, Inc. 81 FR 22122 April 14, 2016

The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed persons.

Dated: August 2, 2016.

Louis J. Milione,
Deputy Assistant Administrator.

[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility